The funding comes on the heels of the launch of its AI platform that expedites the review of surgical procedures.
Photos have been modified. Courtesy of Max Pixel CC0.
Theator, a San Mateo, Calif. and Israel-based artificial intelligence (AI)-powered surgical decision support company, today announced the closing of a $3 million funding round to enhance surgical performance and reduce medical errors with AI.
The funding was led by StageOne, iAngels and KdTVC.
The company leverages machine learning and computer-vision to identify, optimize and scale dissemination of best surgical practices.
“Lack of access to objective and widespread data on surgery is a major cause of often life-threatening errors,” said Tamir Wolf, M.D., co-founder and CEO of Theator. “Today much of the lack of access to quality care stems from surgery being mostly subjective, still taught and performed as an apprenticeship.”
Using Theator’s technology, Wolf believes that there could be a dramatic reduction of biases in surgical procedures.
Along with the funding, Theator also announced the launch of its first product, Minutes, at the Society of American Gastrointestinal and Endoscopic Surgeries meeting in Baltimore, Md., in early April.
Minutes gives AI-edited versions of surgical procedures covering surgical steps and outcome-critical components. Theator claims that the use of its technology can review hours-long procedures in minutes, giving surgeons more time to prepare and review the procedures on their own.
Yoav Samet, managing partner of StageOne and incoming board member of Theator, believes that machine learning and computer vision will change surgery forever, and that identifying best practices to enhance surgeons is just the start.
“We are confident that Theator’s AI-powered solution will be transformative for the way physicians learn to master surgical techniques and reduce errors, making patient outcomes markedly better,” said Mor Assia, founding partner and co-CEO of iAngels.
Navigate the digital transformation with confidence. Register for our newsletter.